Mucopolysaccharide polysulphate

DB16564InvestigationalSmall molecule

Mucopolysaccharide polysulphate is an anti-inflammatory and anticoagulant indicated in the treatment of bruising and varicose veins.

Mechanism
Curator reviewed
Also known as
MPS · Mucopolysaccharide polysulfate

Resolves to

Clinical / RWD
RxNorm30320
Targets
P15514AREG

What you can answer from here — as of August 28, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
13Marketed productsAcross 3 countries and 4 labellers
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Mucopolysaccharide polysulphate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In